Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Change in Accured Expenses (2022 - 2025)

Historic Change in Accured Expenses for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$116000.0.

  • PAVmed's Change in Accured Expenses changed N/A to -$116000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $771000.0, marking a year-over-year change of. This contributed to the annual value of -$304000.0 for FY2024, which is 11086.1% down from last year.
  • Latest data reveals that PAVmed reported Change in Accured Expenses of -$116000.0 as of Q3 2025.
  • Over the past 5 years, PAVmed's Change in Accured Expenses peaked at $1.2 million during Q2 2023, and registered a low of -$1.6 million during Q1 2022.
  • Over the past 4 years, PAVmed's median Change in Accured Expenses value was $208000.0 (recorded in 2022), while the average stood at $235928.6.
  • In the last 5 years, PAVmed's Change in Accured Expenses surged by 1806666.67% in 2023 and then crashed by 25584.42% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Change in Accured Expenses stood at $775000.0 in 2022, then surged by 31.48% to $1.0 million in 2023, then plummeted by 37.78% to $634000.0 in 2024, then tumbled by 118.3% to -$116000.0 in 2025.
  • Its Change in Accured Expenses stands at -$116000.0 for Q3 2025, versus $493000.0 for Q2 2025 and -$240000.0 for Q1 2025.